Eggs-tra Protection: Gonadotropin releasing hormone agonist (GnRHa) use for fertility preservation in pediatric patients receiving chemotherapy

---

ONLINEABSCCMOC

Pop-up Blockers

Thursday, November 21, 2024, 1:00 AM - Saturday, November 21, 2026, 11:59 PM


AMA PRA Category 1 Credits™ (0.75 hours), AAPA Credit(s) (0.75 hours), ABS CC (0.75 hours), ACPE Contact Hour(s) (0.75 hours), ANCC Contact Hour(s) (0.75 hours), IPCE Credit(s) (0.75 hours), Non-Physician Attendance (0.75 hours)

Nearly 15,000 children are diagnosed with cancer in the United States every year. Thankfully, due to advancements in treatment and supportive care, pediatric cancer survival rates have improved drastically over the last few decades. With improved survival rates it is important to think about the long term consequences of treatments used in pediatric cancer, such as infertility. Infertility is a potential side effect of many chemotherapy regimens used in pediatric cancer. Current options for fertility preservation in pediatric patients are limited, and can be expensive or invasive. Data supports the use of gonadotropin releasing hormone analogs (GnRHa) for fertility preservation in adult patients with breast cancer, but there is limited data in other types of cancer as well as in adolescent patients in general. This presentation will review the literature to clarify if GnRHa use is appropriate in the pediatric population.

1. Explain why fertility preservation is needed for patients getting chemotherapy
2. Describe the mechanism of GnRH agonists in fertility preservation
3. Analyze current literature on the use of GnRH agonists for fertility preservation in pediatrics

This activity was planned by and for the healthcare team, and learners will receive 0.75 IPCE credits for learning and change.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected]

Ascension reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Ascension is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CE/CME Coordinator.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Ascension adheres to ACCME Criteria, Standards and Policies regarding industry support of CE/CME. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Ascension adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.